Category Archives for News

FDA Approves CORLANOR (Ivabradine) Oral Solution to Reduce the Risk of Hospitalization for Worsening Heart Failure in Adult Patients with Chronic Heart Failure and for the Treatment of Heart Failure due to Dilated Cardiomyopathy in Pediatric Patients Aged 6 Months and Older.

On April 22, 2019, the U.S. Food and Drug Administration (FDA) approved CORLANOR (ivabradine) oral solution to reduce the risk of hospitalization for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with reduced left ventricular ejection fraction and for the treatment of stable symptomatic heart failure due to dilated cardiomyopathy (DCM) […]

New Issue of NCCIH Update: Message from the Director on Pain Research

National Center for Complementary and Integrative Health sent this bulletin at 05/22/2019 07:48 AM EDT Click here to view in browser.AnnouncementsNCCIH Director’s Message: Perspectives on Pain ResearchNCCIH colleagues and I recently participated in the American Pain Society Scientific Meeting in Milwaukee, Wisconsin. The meeting centered on the theme “Combating the Opioid Epidemic Through Innovations in the […]

FDA: Federal court enters consent decree against Texas compounder, Pharm D Solutions, LLC to cease the manufacturing of drugs intended to be sterile due to insanitary conditions

May 22, 2019 U.S. District Judge Keith P. Ellison for the Southern District of Texas signed and entered a consent decree of permanent injunction, ordering a Texas-based company and its owners to stop producing compounded drugs intended to be sterile until the company complies with the Federal Food, Drug, and Cosmetic Act (FD&C Act) and […]

Federal judge enters consent decree against compounder PharMedium Services for violations at multiple facilities

U.S. District Judge Virginia M. Kendall for the Northern District of Illinois entered a consent decree of permanent injunction today between the United States and PharMedium Services, LLC, headquartered in Lake Forest, Ill., as well as Scott Aladeen, the company’s president, and Warren Horton, vice president for Quality and Research and Development. The company has […]

>